Changes in the rate of clinical and radiologic progression in FTDP-17 associated with lithium administration

被引：0
|
作者：
Boeve, B
Shiung, M
Jack, C
Knopman, D
Smith, G
Ivnik, R
Hutton, M
Tremont-Lukats, I
Waclawik, A
Murrell, J
Koppikar, V
Ghetti, B
Petersen, R
机构：
[1] Mayo Clin & Mayo Fdn, Coll Med, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Jacksonville, FL 32224 USA
[3] Mayo Clin & Mayo Fdn, Robert H & Clarice Smith & Abigail Van Buren Alzh, Rochester, MN 55905 USA
[4] Med Univ S Carolina, Charleston, SC 29425 USA
[5] Univ Wisconsin, Madison, WI 53706 USA
[6] Indiana Univ, Sch Med, Indianapolis, IN USA
[7] Monroe Clin, Monroe, WI USA
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2005年 / 238卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S279 / S279
页数：1
相关论文
共 50 条
  • [11] FTDP-17 associated with the MAPT P301L mutation and severe brainstem pathology
    Gener, M. A. H.
    Murrell, J. R.
    Oblak, A. L.
    Ghetti, B.
    BRAIN PATHOLOGY, 2014, 24 : 70 - 70
  • [12] Clinical and genetic studies of families with the tau N279K mutation (FTDP-17)
    Tsuboi, Y
    Baker, M
    Hutton, ML
    Uitti, RJ
    Rascol, O
    Delisle, MB
    Soulages, X
    Murrell, JR
    Ghetti, B
    Yasuda, M
    Komure, O
    Kuno, S
    Arima, K
    Sunohara, N
    Kobayashi, T
    Mizuno, Y
    Wszolek, ZK
    NEUROLOGY, 2002, 59 (11) : 1791 - 1793
  • [13] Clinical, pathologic and genetic studies of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) associated with the exon 10%3 mutation in the Tau gene
    Ghetti, B
    Murrell, JR
    Epperson, F
    Farlow, MR
    Goedert, M
    Spillantini, M
    MOVEMENT DISORDERS, 2004, 19 : S338 - S339
  • [14] Progression of brain atrophy correlates with impaired performance on selective cognitive functions in frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17)
    Spina, S
    Murrell, J
    Kareken, D
    Unverzagt, F
    Farlow, M
    Ghetti, B
    NEUROLOGY, 2006, 66 (05) : A55 - A55
  • [15] Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation
    Morino, Hiroyuki
    Kurashige, Takashi
    Matsuda, Yukiko
    Ono, Maiko
    Sahara, Naruhiko
    Miyasaka, Tomohiro
    Soeda, Yoshiyuki
    Shimada, Hitoshi
    Yamazaki, Yu
    Takahashi, Tetsuya
    Izumi, Yuishin
    Ito, Hidefumi
    Maruyama, Hirofumi
    Higuchi, Makoto
    Arihiro, Koji
    Suhara, Tetsuya
    Takashima, Akihiko
    Kawakami, Hideshi
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (06): : 720 - 727
  • [16] Diffuse loss of myelin in FTDP-17 associated with mutation N279k in the Tau gene.
    Ghetti, B
    Dickson, D
    Rascol, O
    Tsuboi, Y
    Murrell, JR
    Wszolek, Z
    Delisle, MB
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (05): : 583 - 583
  • [17] Antisense RNA-induced exon-skipping for the gene therapy of frontotemporal dementia and parkinsonism associated with chromosome 17 (FTDP-17)
    Covello, G.
    Siva, K.
    Denti, A. M.
    FEBS JOURNAL, 2012, 279 : 509 - 509
  • [18] Antisense RNA-induced exon-skipping for the gene therapy of frontotemporal dementia and Parkinsonism associated with chromosome 17 (FTDP-17)
    Covello, G.
    Siva, K.
    Fontana, F.
    Bacchi, N.
    Denti, M. A.
    FEBS JOURNAL, 2011, 278 : 326 - 326
  • [19] Clinical and Genetic Study of the First Japanese FTDP-17 Patient with a Mutation of+3 in Intron 10 in the MAPT Gene
    Nan, Haitian
    Takaki, Ryusuke
    Shimozono, Keisuke
    Ichinose, Yuta
    Koh, Kishin
    Takiyama, Yoshihisa
    INTERNAL MEDICINE, 2019, 58 (16) : 2397 - 2400
  • [20] Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation)
    Arvanitakis, Zoe
    Witte, Robert J.
    Dickson, Dennis W.
    Tsuboi, Yoshio
    Uitti, Ryan J.
    Slowinski, Jerzy
    Hutton, Michael L.
    Lin, Siong-Chi
    Boeve, Bradley F.
    Cheshire, William P.
    Pooley, Robert A.
    Liss, Julie M.
    Caviness, John N.
    Strongosky, Audrey J.
    Wszolek, Zbigniew K.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 (04) : 230 - 239
12345